参考来源: ESMO Gynaecological Cancers Congress 2024 - ESMO Gynaecological Cancers Congress 2024 - ABSTRACT SUBMISSION (ctimeetingtech.com) — END — 汇集最新最全的肿瘤资讯 欢迎关注CCMTV临床频道·肿瘤之音!
Abstract submission deadlines 点此提交摘要>>>Submit Abstract>>> ESMO Gynaecological Cancers Congress 2024 Abstract Regulations Abstract submission categories Basic and translational research Cervical cancer Endometrial cancer Ovarian cancer Miscellaneous Outcome notifications Outcome notifications of regular abstracts ...
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid July 2024, in the section “Information for Presenters”. Abstract submission categories-摘要提交类别 *Abstracts may also be submitted to the Cancer nursing track. Subm...
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid July 2024, in the section “Information for Presenters”. Abstract submission categories-摘要提交类别 *Abstracts may also be submitted to the Cancer nursing track. Subm...
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid-September 2024, in the section “Information for Presenters”. Abstract submission categories Late-breaking abstracts (LBA) ...
Those interested in learning more can visit www.Pfizer.com/apls to access the summaries starting September 16, 2024. BREAST CANCER Mini Oral Presentation (Abstract 618MO) Saturday, September 14, 2:45 PM-4:15 PM CEST Phase 1b/2 first-in-class novel combination trial of next generation...
--AbbVie today announced that new data from its innovative antibody-drug conjugate platform will be showcased at the upcoming European Society for Medical Oncology Congress 2024. Presentations include data on mirvetuximab soravtansine and c-Met targeting
Abstract submission categories Biomarkers and translational research and precision medicine Early breast cancer: Adjuvant therapy Early breast cancer: Neoadjuvant therapy Early breast cancer: Surgery and radiotherapy Early detection, hereditary breast cancer and prevention ...
提交指南>>>ESMO Sarcoma and Rare Cancers 2024 Abstract Regulations Submission categories Central Nervous System (CNS) Digestive cancers Genitourinary cancers Gynaecological cancers Head and neck cancers Neuroendocrine and Endocrine cancers Public Policy and Patient Advocacy ...
The final late-breaking abstract deadline of 6 November 2024 is under no circumstances to be considered as an extension of the general submission deadline (1 October 2024). Trial in Progress abstracts Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III)...